Bayer Pharma AG et al v. Accord Healthcare Inc. et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jul 29, 2021 | 13 | Order (2) Docket Text: SO ORDERED Granting [12] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/29/2021. (nms) |
Jul 29, 2021 | 14 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (Attachments: # (1) Order)(nms) |
Jul 29, 2021 | 14 | Order (2) |
Jul 28, 2021 | 11 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of All Defendants (Capuzzi, Kevin) |
Jul 28, 2021 | 12 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
Jul 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 8/2/2021; Accord Healthcare Limited answer due 8/2/2021; Intas Pharmaceuticals Limited answer due 8/2/2021). Signed by Judge Richard G. Andrews on 7/19/2021. (nms) |
Jul 19, 2021 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Accord Healthcare Inc., Accord Healthcare Limited and Intas Pharmaceuticals Limited to move, answer, or otherwise respond to Plaintiffs' Complaint to August 2, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
Jul 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION and Proposed Order Extending Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 7/19/2021; Accord Healthcare Limited answer due 7/19/2021; Intas Pharmaceuticals Limited answer due 7/19/2021). Signed by Judge Richard G. Andrews on 7/6/2021. (nms) |
Jul 6, 2021 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order Extending Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/6/2021 (nms). |
May 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 7/5/2021; Accord Healthcare Limited answer due 7/5/2021; Intas Pharmaceuticals Limited answer due 7/5/2021). Signed by Judge Richard G. Andrews on 5/10/2021. (nms) |
May 10, 2021 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Blumenfeld, Jack) Modified on 5/10/2021 (nms). |
Apr 28, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Apr 22, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT filed against Accord Healthcare Inc., Accord Healthcare Limited, Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3599155.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
Apr 22, 2021 | 1 | Exhibit A (26) |
Apr 22, 2021 | 1 | Civil Cover Sheet (1) |
Apr 22, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
Apr 22, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/9/2021. Date of Expiration of Patent: 01/31/2039. (apk) |
Apr 22, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (apk) |
Apr 22, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (apk) |
Apr 22, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (apk) |
Apr 22, 2021 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (apk) |
Apr 22, 2021 | 1 | Complaint* (1) |